Publications

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

Bonovas S

Clin Gastroenterol Hepatol. 2016 May 14;14(10):1385-1397.e10. doi: 10.1016/j.cgh.2016.04.039

Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.

Marcucci M

BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785

Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response.

Correale C

Gastroenterology. 2012 Oct 26;144(2):346-356.e3. doi: 10.1053/j.gastro.2012.10.040

Biomarkers in psoriatic arthritis: a systematic literature review.

Generali E

Expert Rev Clin Immunol. 2016 Feb 24;12(6):651-60. doi: 10.1586/1744666X.2016.1147954

Bone morphogenetic protein 15 (BMP15) acts as a BMP and Wnt inhibitor during early embryogenesis.

Di Pasquale E, Brivanlou AH

J Biol Chem. 2009 Jun 24;284(38):26127-36. doi: 10.1074/jbc.M109.036608

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

Santoro A

J Clin Oncol. 2016 Jul 5;34(27):3293-9. doi: 10.1200/JCO.2016.66.4466

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.

Carlo-Stella C

Oncologist. 2015 Feb 10;20(3):323-8. doi: 10.1634/theoncologist.2014-0420

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.

Locatelli SL

Leukemia. 2014 Feb 24;28(9):1861-71. doi: 10.1038/leu.2014.81

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Castagna L

Biol Blood Marrow Transplant. 2014 Feb 13;20(5):724-9. doi: 10.1016/j.bbmt.2014.02.001

Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.

Di Nicola M

Clin Cancer Res. 10(16):5381-90.